Vazegepant
Vazegepant (Zavegepant) is a selective, orally administered CGRP receptor antagonist used in migraine research. It is employed in both in vitro binding assays and in vivo models to study CGRP-mediated pathways and mechanisms of pain relief.
Product Specifications
CAS Number
1337918-83-8
Product Name Alternative
BMS-742413, BHV3500, BHV-3500, BHV 3500, CGRPReceptor, CGRP Receptor, Zavegepant, Vazegepant
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
98.61% (May vary between batches)
Solubility
DMSO:30 mg/mL (46.96 mM)
Smiles
O=C1C (=CC=2C (N1) =CC=CC2) C3CCN (C (N[C@H] (CC=4C=C5C (=C (C) C4) NN=C5) C (=O) N6CCN (CC6) C7CCN (C) CC7) =O) CC3
Molecular Formula
C36H46N8O3
Molecular Weight
638.80
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7039029-01 0.02 mg
Recombinant Oryza sativa subsp. japonica ASC1-like protein 3 (Os03g0264000, LOC_Os03g15750)
Sign In for Pricing
View Details MBS7039029-02 0.1 mg
Recombinant Oryza sativa subsp. japonica ASC1-like protein 3 (Os03g0264000, LOC_Os03g15750)
Sign In for Pricing
View Details MBS7039029-03 5x 0.1 mg
Recombinant Oryza sativa subsp. japonica ASC1-like protein 3 (Os03g0264000, LOC_Os03g15750)
Sign In for Pricing
View Details 